Literature DB >> 15057490

The role of molecular imaging in precision radiation therapy for target definition, treatment planning optimisation and quality control.

Giovanni Lucignani, Barbara A Jereczek-Fossa, Roberto Orecchia.   

Abstract

Mesh:

Year:  2004        PMID: 15057490     DOI: 10.1007/s00259-004-1517-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  34 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Dual-modality PET/CT tomography for clinical oncology.

Authors:  T Beyer; D W Townsend; T M Blodgett
Journal:  Q J Nucl Med       Date:  2002-03

Review 3.  Algorithms for radiological image registration and their clinical application.

Authors:  D J Hawkes
Journal:  J Anat       Date:  1998-10       Impact factor: 2.610

Review 4.  Incorporating functional imaging information into radiation treatment.

Authors:  J Rosenman
Journal:  Semin Radiat Oncol       Date:  2001-01       Impact factor: 5.934

5.  Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings.

Authors:  M E Hebert; V J Lowe; J M Hoffman; E F Patz; M S Anscher
Journal:  Am J Clin Oncol       Date:  1996-08       Impact factor: 2.339

6.  CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers.

Authors:  P Giraud; D Grahek; F Montravers; M F Carette; E Deniaud-Alexandre; F Julia; J C Rosenwald; J M Cosset; J N Talbot; M Housset; E Touboul
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-04-01       Impact factor: 7.038

7.  The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas.

Authors:  M W Gross; W A Weber; H J Feldmann; P Bartenstein; M Schwaiger; M Molls
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-07-15       Impact factor: 7.038

8.  [Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors].

Authors:  A N Rahn; R P Baum; I A Adamietz; S Adams; S Sengupta; S Mose; S B Bormeth; G Hör; H D Böttcher
Journal:  Strahlenther Onkol       Date:  1998-07       Impact factor: 3.621

9.  The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer.

Authors:  J D Kiffer; S U Berlangieri; A M Scott; G Quong; M Feigen; W Schumer; C P Clarke; S R Knight; F J Daniel
Journal:  Lung Cancer       Date:  1998-03       Impact factor: 5.705

Review 10.  Nuclear medicine imaging to predict response to radiotherapy: a review.

Authors:  Christophe Van de Wiele; Christophe Lahorte; Wim Oyen; Otto Boerman; Ingeborg Goethals; Guido Slegers; Rudi Andre Dierckx
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-01-01       Impact factor: 7.038

View more
  1 in total

1.  Update on clinical radiobiology.

Authors:  N Chawapun
Journal:  Biomed Imaging Interv J       Date:  2006-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.